Código QR (código de barras bidimensional)

Final Results of a Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma

Abstract Introduction Patients with pretreated relapsed/refractory multiple myeloma (RRMM) have a poor prognosis and limited treatment options, underscoring the need for safe treatments with durable efficacy. Methods This Phase 2 study evaluated magrolimab (Magro) plus daratumumab (Dara) or pomalido...

Fuld beskrivelse

Na minha lista:
Principais autores: Barry Paul, Jiri Minarik, Francesca Cottini, Cristina Gasparetto, Jack Khouri, Mitul Gandhi, Jens Hillengass, Moshe Levy, Michaela Liedtke, Sudhir Manda, Irwindeep Sandhu, Douglas Sborov, Ivan Spicka, Saad Usmani, Mei Dong, Lin Gu, Carmen Leung, Parul Doshi, Christine Chen, Ludek Pour
Format: Artigo
Sprog:Inglês
Udgivet: Wiley 2025-06-01
Serier:eJHaem
Fag:
carfilzomib
daratumumab
dexamethasone
magrolimab
pomalidomide
relapsed/refractory multiple myeloma
Online adgang:https://doi.org/10.1002/jha2.70072
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker